CDMO News
Kenox Pharmaceuticals Adds Small-Scale GMP Capabilities for Nasal and Inhaled Drugs
Kenox Pharmaceuticals Inc. has expanded its drug development services by introducing small-scale non-sterile GMP capabilities to support GLP preclinical studies. The company, focused on Orally Inhaled and Nasal Drug Products (OINDPs), aims to accelerate drug development by providing a streamlined
29 January 2025